SCTB10
/ Sinocelltech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 30, 2026
A Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, PK/PD Characteristics, and Efficacy of SCTB10
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Sinocelltech Ltd.
New P1 trial • Hematological Disorders • Hemophilia • Hemophilia A • Rare Diseases
1 to 1
Of
1
Go to page
1